“The US Food and Drug Administration (FDA) has approved the first-ever system of mobile medical apps that allow real-time data to be shared between a continuous glucose monitor and mobile devices such as an Apple iPhone. The Dexcom Share Direct Secondary Displays system is the first wireless device that allows caregivers or other designated ‘followers’ to remotely monitor glucose levels of a person with diabetes.” Read the full story and see WLSA’s comment on the news below.
“Dexcom has obtained the FDA approval for the first application enabling real time sharing of information from a continuous glucose meter and mobile consumer devices. This is a logical development for the convergence of everyday consumer technology and the highest classification of medical devices. It answers the needs of caregivers who are determined to stay on top of the needs of their dependent children or aging parents. We applaud Dexcom for its persistence and FDA for taking this important step to accelerate the adoption of connected health technologies.” – Rob McCray, WLSA